作者: G.B. Cassano , P. Castrogiovanni , M. Mauri , G. Rutigliano , R. Pirro
DOI: 10.1016/0364-7722(81)90061-8
关键词: Minnesota Multiphasic Personality Inventory 、 Clomipramine 、 Haloperidol 、 Psychology 、 Randomized controlled trial 、 Clinical efficacy 、 In patient 、 Anesthesia 、 Diazepam 、 Multicenter trial 、 General Pharmacology, Toxicology and Pharmaceutics 、 Pharmacology (medical) 、 General Neuroscience 、 Psychiatry and Mental health 、 General Medicine
摘要: Abstract 1. Chlorimipramine has been reported to be effective in the treatment of phobic-obsessive patients. It widely used combination with anti-anxiety compounds such as benzodiazepines, or major tranquillizers, butirophenones, but no clear-cut superiority anyone these treatments yet established. 2. A multicenter trial was performed compare therapeutic characteristics chlorimipramine alone those displayed haloperidol diazepam patients showing an obsessive and/or phobic sympomatology. 3. total 54 inpatients both sexes were admitted a 60-day and treated double-blind conditions. The experiment carried-out three groups: chlorimipramine, diazepam, haloperidol. 4. psychopatological picture evaluation clinical efficacy assessed by battery instruments: MMPI, RSD Hamilton, BPRS Overall Gorham IMPS Lorr. For safety check-list side-effects used. 5. After statistical processing, data gathered from various centres seem indicate differentiated types response all treatments. These suggest possible differentiation use